Chicago, IL, United States of America

Mary Lou Schmidt

This inventor holds 1 USPTO granted patent. Top assignee: University of Illinois. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mary Lou Schmidt. Retrieved from https://idiyas.com/inventor/mary-lou-schmidt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mary Lou Schmidt: Innovator in Cancer Treatment

Introduction

Mary Lou Schmidt is a prominent inventor based in Chicago, IL, known for her groundbreaking work in cancer treatment. She has made significant contributions to the field of oncology through her innovative research and development of therapeutic methods.

Latest Patents

Mary Lou Schmidt holds a patent for a method and composition for treating cancers. This patent, which is focused on preventing or inhibiting tumor growth, discloses a composition that treats malignant cancers without toxic side effects. The active compound in her composition is betulinic acid or a derivative thereof, showcasing her commitment to developing safer cancer therapies.

Career Highlights

Mary Lou Schmidt is affiliated with the University of Illinois, where she continues her research and development efforts. Her work has garnered attention for its potential to revolutionize cancer treatment and improve patient outcomes.

Collaborations

Throughout her career, Mary Lou Schmidt has collaborated with notable colleagues, including John M. Pezzuto and Lydia Ling-Indeck. These partnerships have enhanced her research and contributed to the advancement of cancer treatment methodologies.

Conclusion

Mary Lou Schmidt's innovative approach to cancer treatment exemplifies the impact of dedicated research in the medical field. Her contributions are paving the way for safer and more effective therapies for cancer patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…